Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Docetaxel in the management of head and neck cancer.
Caponigro F, Longo F, Perri F, Ionna F. Caponigro F, et al. Among authors: perri f. Anticancer Drugs. 2009 Sep;20(8):639-45. doi: 10.1097/cad.0b013e32832c9c51. Anticancer Drugs. 2009. PMID: 19639668 Review.
New treatment approaches in renal cell carcinoma.
Facchini G, Perri F, Caraglia M, Pisano C, Striano S, Marra L, Fiore F, Aprea P, Pignata S, Iaffaioli RV. Facchini G, et al. Among authors: perri f. Anticancer Drugs. 2009 Nov;20(10):893-900. doi: 10.1097/CAD.0b013e32833123d4. Anticancer Drugs. 2009. PMID: 19752718 Review.
Treatment approaches to nasopharyngeal carcinoma: a review.
Caponigro F, Longo F, Ionna F, Perri F. Caponigro F, et al. Among authors: perri f. Anticancer Drugs. 2010 Jun;21(5):471-7. doi: 10.1097/CAD.0b013e328337160e. Anticancer Drugs. 2010. PMID: 20124988 Review.
Multidisciplinary approach to patient with malignant melanoma.
Scarpati GD, Fusciello C, Sabbatino F, Ferrone S, Caponigro F, Perri F, Carlomagno C, Pepe S. Scarpati GD, et al. Among authors: perri f. Anticancer Agents Med Chem. 2013 Jul 1;13(6):887-900. doi: 10.2174/18715206113139990079. Anticancer Agents Med Chem. 2013. PMID: 23272971
Induction chemotherapy with docetaxel, cisplatin and capecitabine, followed by combined cetuximab and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck: a phase I-II study.
Perri F, Muto P, Argenone A, Ionna F, Longo F, Fulciniti F, Sandomenico F, Daponte A, Caponigro F. Perri F, et al. Oncology. 2013;84(4):251-4. doi: 10.1159/000347232. Epub 2013 Feb 20. Oncology. 2013. PMID: 23428719 Clinical Trial.
Combined chemo-radiotherapy in locally advanced nasopharyngeal carcinomas.
Perri F, Della Vittoria Scarpati G, Buonerba C, Di Lorenzo G, Longo F, Muto P, Schiavone C, Sandomenico F, Caponigro F. Perri F, et al. World J Clin Oncol. 2013 May 10;4(2):47-51. doi: 10.5306/wjco.v4.i2.47. World J Clin Oncol. 2013. PMID: 23696962 Free PMC article.
Hyalinizing clear cell carcinoma of the parotid gland: report of a recurrent case with aggressive cytomorphology and behavior diagnosed on fine-needle cytology sample.
Fulciniti F, Pia Curcio M, Liguori G, Aquino G, Botti G, Campanile AC, De Cecio R, Pavone E, Aversa C, Perri F, Caponigro F, Ionna F. Fulciniti F, et al. Among authors: perri f. Diagn Cytopathol. 2014 Jan;42(1):63-8. doi: 10.1002/dc.22956. Epub 2013 Jul 27. Diagn Cytopathol. 2014. PMID: 23894005
Ipilimumab in the treatment of metastatic melanoma: management of adverse events.
Della Vittoria Scarpati G, Fusciello C, Perri F, Sabbatino F, Ferrone S, Carlomagno C, Pepe S. Della Vittoria Scarpati G, et al. Among authors: perri f. Onco Targets Ther. 2014 Feb 19;7:203-9. doi: 10.2147/OTT.S57335. eCollection 2014. Onco Targets Ther. 2014. PMID: 24570590 Free PMC article. Review.
Optimal management of a patient with recurrent nasopharyngeal carcinoma.
Perri F, Dell'Oca I, Muto P, Schiavone C, Aversa C, Fulciniti F, Solla R, Scarpati GD, Buonerba C, Di Lorenzo G, Caponigro F. Perri F, et al. World J Clin Cases. 2014 Jul 16;2(7):297-300. doi: 10.12998/wjcc.v2.i7.297. World J Clin Cases. 2014. PMID: 25032207 Free PMC article.
Targeted therapy: a new hope for thyroid carcinomas.
Perri F, Pezzullo L, Chiofalo MG, Lastoria S, Di Gennaro F, Scarpati GD, Caponigro F. Perri F, et al. Crit Rev Oncol Hematol. 2015 Apr;94(1):55-63. doi: 10.1016/j.critrevonc.2014.10.012. Epub 2014 Nov 1. Crit Rev Oncol Hematol. 2015. PMID: 25465739 Review.
Brooke-Spiegler syndrome presenting multiple concurrent cutaneous and parotid gland neoplasms: cytologic findings on fine-needle sample and description of a novel mutation of the CYLD gene.
Malzone MG, Campanile AC, Losito NS, Longo F, Perri F, Caponigro F, Schiavone C, Ionna F, Maiello F, Martinuzzi C, Nasti S, Botti G, Fulciniti F. Malzone MG, et al. Among authors: perri f. Diagn Cytopathol. 2015 Aug;43(8):654-8. doi: 10.1002/dc.23275. Epub 2015 May 21. Diagn Cytopathol. 2015. PMID: 25995191
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen.
Perri F, Pisconti S, Conson M, Pacelli R, Della Vittoria Scarpati G, Gnoni A, D'Aniello C, Cavaliere C, Licchetta A, Cella L, Giuliano M, Schiavone C, Falivene S, Di Lorenzo G, Buonerba C, Ravo V, Muto P. Perri F, et al. Onco Targets Ther. 2015 Jun 8;8:1345-9. doi: 10.2147/OTT.S75232. eCollection 2015. Onco Targets Ther. 2015. PMID: 26089683 Free PMC article.
Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas.
Della Vittoria Scarpati G, Perri F, Pisconti S, Costa G, Ricciardiello F, Del Prete S, Napolitano A, Carraturo M, Mazzone S, Addeo R. Della Vittoria Scarpati G, et al. Among authors: perri f. Mol Clin Oncol. 2016 Apr;4(4):467-471. doi: 10.3892/mco.2016.746. Epub 2016 Jan 27. Mol Clin Oncol. 2016. PMID: 27073643 Free PMC article.
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
Caponigro F, Di Gennaro E, Ionna F, Longo F, Aversa C, Pavone E, Maglione MG, Di Marzo M, Muto P, Cavalcanti E, Petrillo A, Sandomenico F, Maiolino P, D'Aniello R, Botti G, De Cecio R, Losito NS, Scala S, Trotta A, Zotti AI, Bruzzese F, Daponte A, Calogero E, Montano M, Pontone M, De Feo G, Perri F, Budillon A. Caponigro F, et al. Among authors: perri f. BMC Cancer. 2016 Nov 25;16(1):918. doi: 10.1186/s12885-016-2957-y. BMC Cancer. 2016. PMID: 27884140 Free PMC article. Clinical Trial.
P53 mutations and cancer: a tight linkage.
Perri F, Pisconti S, Della Vittoria Scarpati G. Perri F, et al. Ann Transl Med. 2016 Dec;4(24):522. doi: 10.21037/atm.2016.12.40. Ann Transl Med. 2016. PMID: 28149884 Free PMC article.
Locally advanced paranasal sinus carcinoma: A study of 30 patients.
Perri F, Addeo R, Conson M, Faiella A, Scarpati GDV, Torre G, Di Biase A, Romanelli P, Buonerba C, Di Lorenzo G, Daponte A, Caponigro F, Pisconti S, Pacelli R, Ravo V, Muto P, Solla R. Perri F, et al. Oncol Lett. 2017 Mar;13(3):1338-1342. doi: 10.3892/ol.2017.5598. Epub 2017 Jan 11. Oncol Lett. 2017. PMID: 28454258 Free PMC article.
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Marra A, Ferrone CR, Fusciello C, Scognamiglio G, Ferrone S, Pepe S, Perri F, Sabbatino F. Marra A, et al. Among authors: perri f. Anticancer Agents Med Chem. 2018;18(2):166-181. doi: 10.2174/1871520618666171219115335. Anticancer Agents Med Chem. 2018. PMID: 29256359 Review.
Thyroid cancer management: from a suspicious nodule to targeted therapy.
Perri F, Giordano A, Pisconti S, Ionna F, Chiofalo MG, Longo F, Leopardo D, Della Vittoria Scarpati G, Pezzullo L. Perri F, et al. Anticancer Drugs. 2018 Jul;29(6):483-490. doi: 10.1097/CAD.0000000000000617. Anticancer Drugs. 2018. PMID: 29649016 Review.
Management of recurrent nasopharyngeal carcinoma: current perspectives.
Perri F, Della Vittoria Scarpati G, Caponigro F, Ionna F, Longo F, Buonopane S, Muto P, Di Marzo M, Pisconti S, Solla R. Perri F, et al. Onco Targets Ther. 2019 Feb 26;12:1583-1591. doi: 10.2147/OTT.S188148. eCollection 2019. Onco Targets Ther. 2019. PMID: 30881013 Free PMC article. Review.
Oral lichen planus and other confounding factors in narrow band imaging (NBI) during routine inspection of oral cavity for early detection of oral squamous cell carcinoma: a retrospective pilot study.
Guida A, Maglione M, Crispo A, Perri F, Villano S, Pavone E, Aversa C, Longo F, Feroce F, Botti G, Ionna F. Guida A, et al. Among authors: perri f. BMC Oral Health. 2019 Apr 30;19(1):70. doi: 10.1186/s12903-019-0762-0. BMC Oral Health. 2019. PMID: 31039762 Free PMC article.
Surgical oncology of the head and neck district during COVID-19 pandemic.
Salzano G, Maglitto F, Guida A, Perri F, Maglione MG, Buonopane S, Muto P, Ionna F. Salzano G, et al. Among authors: perri f. Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3107-3111. doi: 10.1007/s00405-020-06517-3. Epub 2021 Jan 4. Eur Arch Otorhinolaryngol. 2021. PMID: 33394125 Free PMC article.
Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial.
Perri F, Longo F, Fusco R, D'Alessio V, Aversa C, Pavone E, Pontone M, Marciano ML, Villano S, Franco P, Togo G, Fazio GR, Ordano D, Maglitto F, Salzano G, Maglione MG, Guida A, Ionna F. Perri F, et al. Cancers (Basel). 2021 May 4;13(9):2210. doi: 10.3390/cancers13092210. Cancers (Basel). 2021. PMID: 34064511 Free PMC article.
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Big and Intriguing Challenge Which May Be Resolved by Integrated Treatments Combining Locoregional and Systemic Therapies.
Ionna F, Bossi P, Guida A, Alberti A, Muto P, Salzano G, Ottaiano A, Maglitto F, Leopardo D, De Felice M, Longo F, Tafuto S, Della Vittoria Scarpati G, Perri F. Ionna F, et al. Among authors: perri f. Cancers (Basel). 2021 May 14;13(10):2371. doi: 10.3390/cancers13102371. Cancers (Basel). 2021. PMID: 34069092 Free PMC article. Review.
Malignant Sinonasal Tumors: Update on Histological and Clinical Management.
Bracigliano A, Tatangelo F, Perri F, Di Lorenzo G, Tafuto R, Ottaiano A, Clemente O, Barretta ML, Losito NS, Santorsola M, Tafuto S. Bracigliano A, et al. Among authors: perri f. Curr Oncol. 2021 Jul 1;28(4):2420-2438. doi: 10.3390/curroncol28040222. Curr Oncol. 2021. PMID: 34287240 Free PMC article. Review.
330 results